• +Who we are
  
  • Welcome letter
  • About Novo Nordisk
  • Management
  • Corporate Governance
    • Framework
    • Organisational structure
    • Shares and voting rights
    • Novo Nordisk Foundation
    • Shareholder's general meeting
    • Board of Directors
    • Chairmanship and board committees
    • Audit Committee
    • Executive Management
    • Remuneration policy
    • Self-assessment
    • Risk management
    • Internal control
    • Assurance
    • Audit
    • Codes and practices
  • Ownership
  • Facts and figures
    • Global offices
  • World map
  • History
• +What we do
  
  • Diabetes care
  • Haemostasis management
  • Growth hormone therapy
  • HRT
  • Pipeline
• +How we perform
  • Access to health
    • Best possible pricing
    • DAWN
    • Health futures
    • Low-income minorities
    • National Changing Diabetes Programme
    • Novo Nordisk Haemophilia Foundation
    • Socio-economics
    • World Diabetes Foundation
    • World Partner Project
  • Advocacy
    • Changing Diabetes Bus
    • Oxford Health Alliance
    • Public policy
    • UN Resolution
    • Youth panel
  • Awards and recognitions
  • Bioethics
    • Animal welfare
    • Clinical trials
    • Gene technology
    • Stem cell research
  • Business ethics
  • Community engagement
    • Donations
    • Employee volunteering
    • Sponsorships
  • Environmental management
    • Climate change
    • Environmental footprint
    • Green accounts
    • Environmentally sound design
    • Product stewardship
  • Financial performance
    • Share information
    • IR contact
  • Human rights
  • Legal issues
  • Key performance data
    • Key performance indicators
  • Interactive charts
  • Quality
    • Patient safety
  • Responsible sourcing
  • Socio-economics
    • Economic footprints
  • Workplace quality
    • Diversity
    • Employee health
    • Health and safety
    • People strategy
    • Talent development
    • Wages and benefits
    • Workplace statistics
• +How we work
  • Vision and strategy
    • Sustainability vision and strategy
    • Business design
  • The Novo Nordisk Way
    • Follow up methodologies
  • Sustainability
  • Triple Bottom Line
  • Compliance
    • Codes, standards and practices
  • Stakeholder engagement
    • Stakeholder overview
    • Memberships
    • Partnerships
  • Risk management
  • Brand and reputation management
  • The business case for corp. responsibility
  • Definitions
    • Non-financial definitions
    • Financial definitions
  • Interactive challenges
    • The Business Ethics Challenge
    • The EnviroMan
    • The Convincer
• +How we are accountable
  • Reporting strategy
  • Audit and assurance
    • What assures?
    • Internal assurance
    • External assurance
  • Accounting policies
  • Materiality
  • Independence statement
  • Auditors' report
    • Recommendations and Novo Nordisk's response
  • GRI
    • Principles
    • GRI index
    • Vision and strategy
    • Profile
    • Governance structure and management systems
    • Performance indicators
    • Economics
    • Environmental
    • Social
    • Labour practices
    • Product responsibility
    • Society
  • Global Compact
    • Communication on progress
  • Stakeholder feedback
• +Downloads
  
  • Downloads
    • View PDF
    • Download report